New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
11:10 EDTFENG, ODP, ARO, NDLS, GPI, KATE, LINTA, ICPT, ACOHigh option volume stocks
High option volume stocks: ACM KATE ARO TKMR ODP ICPT GPI FENG LINTA NDLS
News For ARO;ACO;KATE;ODP;ICPT;GPI;FENG;LINTA;NDLS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
16:17 EDTAROAeropostale announces changes to board
Aéropostale announced future changes to the composition of its board. Robert Chavez has advised the company that he will not seek re-election to the company's board at the 2015 Annual Stockholder Meeting due to his responsibilities and time commitments as president and CEO of Hermes of Paris. Chavez will continue to serve until the 2015 Annual Meeting. Stefan Kaluzny has also advised the company that he will not seek re-election as a Director at the 2015 Annual Stockholder Meeting. Kaluzny, a Managing Director of Sycamore Partners, has served as a designated Series B Director since May 2014. He will also continue to serve until the 2015 Annual Meeting.
10:06 EDTKATEKate Spade May call activity attributed to takeover chatter
Subscribe for More Information
05:44 EDTICPTIntercept FLINT trial data shows OCA treatment increases fibrosis resolution
Subscribe for More Information
April 22, 2015
07:07 EDTICPTEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.
April 20, 2015
08:18 EDTKATEMichael Kors downgraded to Neutral with $70 target at Mizuho
Subscribe for More Information
April 17, 2015
10:00 EDTICPTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:53 EDTICPTIntercept initiated with a Buy, $465 target at UBS
UBS analyst Matthew Roden started shares of Intercept Pharmaceuticals with a Buy rating and $465 price target. Roden sees a favorable risk/reward ahead of the approval and commercial launch of the company's obeticholic acid, known as OCA, in primary biliary cirrhosis. Roden also thinks OCA's opportunity in nonalcoholic steatohepatitis is being undervalued at current share levels. Shares of Intercept closed yesterday up $2.53 to $274.44.
April 15, 2015
10:00 EDTAROOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:56 EDTAROAeropostale initiated with a Neutral at Guggenheim
April 14, 2015
09:20 EDTKATEKate Spade's department store sales strong during Q1, says OTR Global
Subscribe for More Information
April 13, 2015
11:28 EDTODPStarboard CEO says Staples, Office Depot merger 'likely to go through'
Says confident the potential merger will pass anti-trust scrutiny. Jeff Smith is speaking on CNBC.
08:24 EDTICPTDeutsche Bank pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
06:07 EDTICPTIntercept announces several presentations evaluating OCA
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use